CHINESE JOURNAL OF MEDICINAL GUIDE >
The Dual Role of Serum Uric Acid Levels in Sepsis-Associated Acute Kidney Injury
Received date: 2025-02-21
Revised date: 2025-05-21
Accepted date: 2025-11-15
Online published: 2025-12-24
Objective: To investigate the correlation between baseline uric acid levels and the occurrence of sepsis-associated acute kidney injury (SA-AKI).Methods: A retrospective cohort study was conducted to analyze 571 sepsis patients admitted to our hospital from January 2019 to December 2024. Patients were divided into the hyperuricemia group (n=147) and the non-hyperuricemia group (n=424) based on serum uric acid levels, and the incidence of SA-AKI was compared between the two groups. Multivariate logistic regression was used to analyze the correlation between hyperuricemia and SA-AKI. A restricted cubic spline (RCS) model was applied to assess the nonlinear relationship between uric acid levels and SA-AKI risk.Results: The overall incidence of SA-AKI in sepsis patients was 51.14%. The hyperuricemia group had a significantly higher SA-AKI incidence than the non-hyperuricemia group (76.7% vs. 42.3%, P<0.001). Intergroup comparisons revealed that, compared to the non-hyperuricemia group, the hyperuricemia group exhibited higher proportions of hypertension, coronary heart disease, baseline chronic kidney disease, and elevated levels of serum creatinine, white blood cells count, lactate levels, and lower baseline eGFR (P<0.05). Multivariate logistic regression analysis showed that hyperuricemia was an independent risk factor for SA-AKI (OR=4.387, P<0.001). RCS analysis demonstrated a nonlinear relationship between uric acid levels and SA-AKI risk (P<0.001). Uric acid levels below 250 μmol·L-1 were negatively correlated with SA-AKI risk, whereas levels above 250 μmol·L-1 were positively correlated.Conclusion: Hyperuricemia is an independent risk factor for SA-AKI, and uric acid has a dual role in the occurrence of SA-AKI. Clinically, monitoring of uric acid levels of sepsis patients should be emphasized to enable early identification and intervention of high-risk populations of SA-AKI.
Key words: Sepsis; Hyperuricemia; Acute kidney injury; Dual role
ZHANG Shuliu, CHEN Yugang, LIU Ruirui, DU Chao, CUI Yunliang
.
The Dual Role of Serum Uric Acid Levels in Sepsis-Associated
Acute Kidney Injury
[1] Weng L, Zeng XY, Yin P, et al. Sepsis-related mortality in China: a descriptive analysis[J].Intensive Care Med,2018,44(7):1071-1080.
[2] 王楠,王美平,姜利,等.脓毒症相关性急性肾损伤发生时间与临床结局的关系[J].中华医学杂志,2024,104(21):1972-1978.
[3] 笪伟,朱甜甜,王晓波,等.VExUS评分在脓毒症合并急性肾损伤患者中的应用价值[J].中华急诊医学杂志,2024,33(3):312-316.
[4] He FF, Wang YM, Chen YY, et al. Sepsis-induced AKI: from pathogenesis to therapeutic approaches[J].Front Pharmacol, 2022,13:981578.
[5] Hu J, Zhou Y, Huang H, et al. Prediction of urinary dickkopf-3 for AKI, sepsis-associated AKI, and PICU mortality in children[J].Pediatr Res, 2023,93(6):1651-1658.
[6] White KC, Serpa-Neto A, Hurford R, et al. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study[J].Intensive Care Med,2023,49(9):1079-1089.
[7] Kim GH, Jun JB. Altered serum uric acid levels in kidney disorders[J].Life (Basel),2022,12(11):1891.
[8] Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3)[J].JAMA, 2016,315(8):775-787.
[9] 中国研究型医院学会.脓毒症诊断与治疗规范(2023)[S].T/CRHA 005-2023
[10] Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J].J Am Soc Nephrol, 2006,17(10):2937-2944.
[11] 张道为,丁莉,朱学专.脓毒症患者入重症监护室时血尿酸水平与微炎症状态的相关性及对肾损伤的预测[J].临床急诊杂志,2024,25(9):478-484.
[12] Zarbock A, Nadim MK, Pickkers P, et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup[J].Nat Rev Nephrol, 2023,19(6):401-417.
[13] 中国民族卫生协会重症代谢疾病分会,高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识(2023年版)[J].中国实用内科杂志,2023,43(6):461-480.
[14] Wiersema R, Jukarainen S, Vaara ST, et al. Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery[J].Crit Care, 2020,24(1):150.
[15] 张江明,齐敏君,马璐妹,等.脓毒症相关性急性肾损伤生物标志物的研究进展[J].中华危重病急救医学,2024,36(11):1216-1220.
[16] 蒋远霞,唐艳,易扬,等.高尿酸血症是脓毒症患者发生急性肾损伤的独立危险因素[J].中华急诊医学杂志,2020,29(9):1178-1183.
[17] Halperin Kuhns VL, Woodward OM. Urate transport in health and disease[J].Best Pract Res Clin Rheumatol, 2021,35(4):101717.
[18] Lee YHA, Chan JSK, Leung CH, et al. Association between serum uric acid and prostate cancer mortality in androgen deprivation therapy: a population-based cohort study[J].Cancer Med, 2023,12(16):17056-17060.
[19] Dai Y, Jiang Y, Zhang L, et al. Moderate elevation of serum uric acid levels improves short-term functional outcomes of ischemic stroke in patients with type 2 diabetes mellitus[J].BMC Geriatr, 2023,23(1):445.
[20] 吴建楠,宋健楠,李海波,等.铁死亡在脓毒症中的研究进展[J].北京医学,2022,44(7):629-632.
[21] Cerceo E, Rachoin JS, Gaughan J, et al. Association of gender, age, and race on renal outcomes and mortality in patients with severe sepsis and septic shock[J].J Crit Care, 2021,61:52-56.
[22] Ostermann M, Zarbock A, Goldstein S, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference[J].JAMA Netw Open, 2020,3(3):e2019209.
[23] Yin PY, Wang RW, Jing R, et al. Research progress on molecular biomarkers of acute myeloid leukemia[J].Front Oncol,2023,13:1078556.
[24] 田梓佑,张杰,聂诗琪,等.自噬在脓毒症急性肾损伤发病机制及治疗中的研究进展[J].中华危重病急救医学,2025,37(2):183-187.
[25] 童俐娜,李花,陆遥,等.基于CiteSpace对国内外近十年关于高尿酸血症发病机制研究的可视化分析[J].中国医药导刊,2024,26(10):1053-1059./
| 〈 |
|
〉 |